Print ISSN:-2394-4781

Online ISSN:-2394-4994

CODEN : IJCACT

Article History

Received : 06-12-2021

Accepted : 04-04-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 579

PDF Downloaded: 345


Perioperative management of patients with post Covid rhino-orbito-cerebral mucormycosis: Prospective observational study


Full Text PDF Share on Facebook Share on Twitter


Original Article

Author Details : Devyani Desai, Neha Shah, Neha Cheraya, Bhoomika Kalarthi*, Sagar Bavisetti, Parvathy D, Abhishek Zala, Kanchan Choube, Gaurav Cheraya

Volume : 9, Issue : 2, Year : 2022

Article Page : 214-219

https://doi.org/10.18231/j.ijca.2022.043



Suggest article by email

Get Permission

Abstract

Background: Mucormycosis is a life-threatening, locally invasive, rapidly progressive, opportunistic fungal infection, associated with several anaesthetic challenges.
Aims: We aimed to study its relation with patient’s comorbidities, covid treatment strategies, also to observe the intubation difficulties, changes in hemodynamic parameters, post anaesthesia recovery status and perioperative complications.
Materials and Methods: In this time bound study, total 160 patients were included. During pre-anaesthetic evaluation, presence of associated co-morbidities, course of Covid-19 disease, requirement of O2 therapy were noted. On the day of surgery, premedications and sedation were given. Induction was done with propofol/etomidate along with sevoflurane/desflurane. Intubation was done with succinyl choline/ atracurium and difficulties in intubation were graded according to Modified Intubation Difficulty Scale. Anaesthesia was maintained with the mixture of Oxygen, Air and inhalation agent along with intermittent Atracurium. Hemodynamic parameters, intra operative and post operative outcome were noted. Unstable patients were shifted to intensive care unit.
Results: Among patients of rhino-orbito-cerebral mucormycosis, most common co morbidity found was diabetes mellitus (42%). Here, 61% were on room air, rest needed oxygen therapy. Total 52% patients required >/= 2 intubation attempts, in which 9% were video laryngoscope assisted and 11% required additional maneuvers. 22% patients were started on intravenous nitroglycerin to manage intraoperative hypertension. 9.3% patients required ICU admission, of which 2.5% could not survive.
Conclusion: Possibilities of developing rhino-orbito-cerebral mucormycosis in patients having diabetes mellitus are high. The anaesthetic management requires eternal vigilance to encounter difficult intubation, delayed recovery, and higher rate of morbidity and mortality.
 

Keywords: COVID- 19, Delayed recovery, Difficult intubation, Rhino-orbito-cerebral mucormycosis



How to cite : Desai D, Shah N, Cheraya N, Kalarthi B, Bavisetti S, Parvathy D, Zala A, Choube K, Cheraya G, Perioperative management of patients with post Covid rhino-orbito-cerebral mucormycosis: Prospective observational study. Indian J Clin Anaesth 2022;9(2):214-219


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.